News
Latest News
University of Michigan Alzheimer's Prevention Study Looking for More Participants
Dr. Judy Heidebrink sits down for an in-depth interview about the AHEAD Study and the latest Alzheimer's research. WEMU Michigan, January 26, 2023
Alzheimer’s Study in Boston Looking at Possible Treatment to Prevent the Disease
Dr. Seth Gale discusses the treatment used in the AHEAD Study and why participating in Alzheimer's research is crucial. Boston Herald, January 26, 2023
Clinical Trial Looking for Participants for New Alzheimer's Drug
The recent approval of a new Alzheimer's drug is opening the door for researchers to expand their work and recruit new participants. KNX Arizona, January 25, 2023
University of Rochester Researchers Studying Alzheimer's Prevention
Dr. Anton Porsteinsson, director of UR's Alzheimer's Disease Care, Research & Education Program discusses the AHEAD Study and what it means for Alzheimer's research. WHAM Rochester, January 24, 2023
OHSU at Frontlines of New Drug Trial Aimed at Preventing Alzheimer’s Disease
The AHEAD Study is the first trial that aims to help prevent Alzheimer’s disease through tailored dosing of an investigational treatment. KGW Portland, January 18, 2023
National Research Teams Seek Alzheimer's Clinical Trial Participants for New Study
Recently, a drug shown to modestly slow the early stages of Alzheimer's was approved by the Food and Drug Administration. WEWS Cleveland, January 16, 2023
Can a Drug Stop Alzheimer’s Before it Starts?
Penn is part of an international trial for people aging without symptoms. Philadelphia Inquirer, December 28, 2022
Alzheimer's Study at UAB
Preventing memory loss due to Alzheimer’s disease is the goal of researchers at the University of Alabama at Birmingham as it continues to be a common disease in the deep south. WVTM 13 Birmingham, December 7, 2022
How Soon Could Lecanemab be Prescribed to Treat Alzheimer's Disease?
Dr. Neelum Aggarwal, a neurologist at Rush Medical Center, talks about lecanemab, a drug which showed promising results in slowing cognitive decline. WLS 7 Chicago, December 6, 2022
Alzheimer’s Clinical Trial Seeks to Prevent Memory Loss
Groundbreaking study seeks diverse volunteers who have been historically underrepresented in research. Nashville Medical News, December 5, 2022
Mass General Brigham Researchers Honored at Conference on Alzheimer’s Disease Therapeutic Trials
Dr. Reisa Sperling and Dr. Keith Johnson were both awarded Lifetime Achievement awards for their contributions to Alzheimer's research. Mass General Brigham, December 1, 2022
Study Underway for New Drug Aimed to Prevent Alzheimer's Disease
AHEAD Study participant Spencer Beard speaks about his experience with Alzheimer's disease and how the study is researching a possible treatment to prevent the disease. KOMO News Seattle, November 9, 2022
The AHEAD Study Takes a Preventative Approach to Alzheimer's Treatment
Dr. Hamid Okhravi of Eastern Virginia Medical School and study participant Carol Turner share their experiences. Utah Public Radio, November 8, 2022
Video: AHEAD Study Participant Carol Turner Discusses the Importance of Black and African American Participation
Researchers working to prevent Alzheimer's disease up to 20 years. November 3, 2022
AHEAD Study Is First To Test Lecanemab To Delay Or Prevent Alzheimer's Disease Symptoms At The Stage Of Preclinical Ad
The Alzheimer's Clinical Trial Consortium (ACTC) will be presenting analyses of screening plasma and neuroimaging data from the AHEAD Study at CTAD in November. November 2, 2022
Alzheimer's Disease Awareness Month
Dr. Hamid Okhravi an Alzheimer’s expert with the Eastern Virginia Medical School and Carol Turner, a current participant in the "AHEAD Study" shared with us their progress. WJLA 7 Washington DC, November 1, 2022
Researchers Working to Prevent Alzheimer's Disease up to 20 Years
Millions are affected by this disease, however, a new study is giving many hope for a possible treatment. WTTG 5 Washington DC, November 1, 2022
Hispanic Heritage Month: Fighting Alzheimer's
Alzheimer’s still has no cure. AHEAD is a research study that is hoping to prevent the disease. WBTS 10 Boston, October 14, 2022
World Alzheimer's Day
Epidemiologist Dr. Christian Salazar of UC Irvine speaks about how Alzheimer's disproportionately affects the Latino community. KCBS 2 Los Angeles, September 21, 2022
New Study Looks Into Alzheimer’s Disease
Alzheimer’s disease is affecting more than six million Americans currently. And now, experts have created the AHEAD study. WBBJ 7 Jackson, June 16, 2022
National Latino Public Radio
A first-of-its-kind study is seeking to understand how Alzheimer’s disease develops in the brain before symptoms appear. National Latino Public Radio, June 16, 2022
Expert Shares Ways To Help Get “AHEAD” Of Dementia
June is Brain Health Awareness Month, and one expert is sharing ways to help get “AHEAD” of dementia. WMC 5 Memphis, June 14, 2022
Watch: Alzheimer's Researchers Seek More AAPI Participation
To mark Asian American and Pacific Islander Heritage Month, researchers are talking about the need for more studies on the impact of Alzheimer’s. KNTV 11 San Francisco, May 11, 2022
America's Healthcare Advocate
Doris Molina-Henry, Ph.D., professor of research neurology at the University of Southern California joins Cary to discuss Alzheimer's. America's Health Advocate, March 28, 2022
A Call for Community Healing: Black Participation in Alzheimer’s Research
In order to elevate the health within underrepresented groups, there is a call for community participation. Los Angeles Sentinel, March 13, 2022
Brigham and Women's Hospital Hopes to Recruit At-Risk Residents for Global Alzheimer's Study
Researchers trying to increase participation from high-risk minority communities. WCVB 5 Boston, March 8, 2022
Alzheimer’s Impacts African Americans at Higher Rates
According to the Alzheimer’s Association, older African Americans are twice as likely as their white counterparts to develop Alzheimer’s Disease. In fact, 21.3 percent of Black Americans over the age of 70 are living with the disease. The Grio, February 9, 2022
‘Bring Some Balance’ — Alzheimer’s Study Needs More Black Participants
Black adults are twice as likely to develop Alzheimer’s disease as white adults, but they make up fewer than 10% of clinical trial participants, so a new study of a treatment is recruiting diverse candidates of every race and ethnicity. WTOP Washington, February 8, 2022
Dr. Crystal Glover Shares How the "AHEAD Study" can Help Black Adults With Alzheimer's
Dr. Crystal Glover shares how the "AHEAD Study" can help black adults with Alzheimer's. KTUL 8 Tulsa, February 8, 2022
Disproportional Impact of Alzheimer's on African Americans
CBS News Bay Area anchor Len Kiese talks to Dr. Doris Molina-Henry, Assistant Professor of Research Neurology at the University of Southern California’s Keck School of Medicine, about how Alzheimer's disease disproportionately affects the African American community. MSN, February 8, 2022
Worldwide Study Hoping to End Alzheimer’s Disease
Two research centers in the Boston area participate in the worldwide “AHEAD Study,” aiming to help prevent Alzheimer’s disease. Researchers are using an experimental drug called BAN 2401 that attacks amyloid plaques that build up in the brain and eventually lead to the devastating disease. WFXT 25 Boston, February 3, 2022
Study to Prevent Alzheimer's Disease now Enrolling Patients in Tampa Bay Area
Alzheimer's disease affects millions of people but disproportionately affects Black people. That's why researchers need to diversify their trial pools. WTSP 10 Florida, February 2, 2022
Tulsa Research Lab is Part of a Worldwide Study to End Alzheimer’s
Central States Research in South Tulsa is participating in the AHEAD Study that aims to help prevent Alzheimer’s disease. Dr. Sarah Land, owner of Central States Research, LLC, says the experimental drug called B-A-N 2-4-0-1 attacks amyloid plaques that build up in the brain and eventually lead to Alzheimer’s. KOKI 23 Tulsa December 30, 2021.
Blood Test Shows Risk Of Developing Alzheimer’s Disease
Clinical trials are underway that indicates a blood test can identify a person’s chance of developing brain amyloid, a protein that is a risk factor in Alzheimer’s disease. November 15, 2021
Alzheimer's Disease may be Detectable by Key Blood Test, Study Finds
A new blood test may identify more than 80% of people with increased likelihood of having amyloid in the brain, a protein that’s a risk factor for developing Alzheimer’s disease, according to a recent study that was presented this week at Boston’s international Clinical Trials on Alzheimer’s Disease conference. November 12, 2021
New Blood Test to Identify People at Risk of Developing Alzheimer's Symptoms Will Be Used in a Clinical Trial Aiming to Prevent Memory Loss
Research presented today highlights advantage of using blood test for a trial that aims to prevent Alzheimer's. Up to 75 research centers across North America will use blood tests to identify those most at-risk for changes in the brain from Alzheimer's disease, thus, expediting prevention research, November 11, 2021
El Uso de Una Prueba de Sangre en un Ensayo Clínico Dirigido a Prevenir la Pérdida de Memoria, Ayudara a Identificar a Personas en Riesgo de Presentar Síntomas de Enfermedad de Alzheimer
Un estudio presentado hoy resalta las ventajas de utilizar pruebas de sangre para ensayo clínico que busca prevenir el Alzheimer. Hasta 75 centros de investigación de toda Norteamérica utilizarán pruebas de sangre. Las pruebas de sangre servirán para identificar a las personas con mayor riesgo de sufrir cambios en el cerebro debido a la enfermedad de Alzheimer. Se anticipa que este descubrimiento ayudará a acelerar las investigaciones sobre su prevención. November 11, 2021
New Research Looking to Identify Alzheimer’s Disease through Blood Test
New research indicates a blood test can be used to identify people with brain amyloid, which is a protein that’s a risk factor for developing Alzheimer’s. November 11, 2021
A New Era for Alzheimer’s Clinical Trials: Blood Tests Help Enroll Younger Participants
New clinical trials on memory loss interventions is currently enrolling participants with key Alzhemier’s biomarkers as young as 55 and 60 years old. Tau and beta-amyloid blood test are helping determine who is eligible. Being Patient, November 11, 2021
A New Study is Testing a Drug That Battles Alzheimer’s Before Signs of Symptoms
Dr. Cherian Verghese joined the show to discuss the new AHEAD Study site at Keystone Clinical Studies in Plymouth Meeting, PA and recruit participants as young as 55 years of age. KYW NewsRadio, August 16, 2021
Alzheimer's Disease Study in San Diego: Local Volunteers are Needed
The Alzheimer’s Therapeutic Research Institute (ATRI) is seeking volunteers in Imperial County. The Desert Review, June 16, 2021
Alzheimer's Treatment Study Seeks Volunteers, Including Two Sites in Portland
The AHEAD Study team is testing a new investigational treatment, examining whether they can slow or stop the earliest brain changes due to Alzheimer’s disease in people with a higher risk of developing the disease later in life. The team is seeking volunteers on its website. KATU 2 Portland, June 15, 2021
Hoag Seeks Volunteers for Early Onset Alzheimer’s Study
Hoag’s Pickup Family Neurosciences Institute in Newport Beach has started the AHEAD Study, which is recruiting people as young as 55 years old who are at risk of developing symptoms of Alzheimer’s as they age. Orange County Register, June 7, 2021
New Alzheimer's Trial Hopes to Prevent Memory Decline
Dr. Reisa Sperling joined the show to recruit participants for the AHEAD Study, a clinical trial that aims to prevent Alzheimer's and create treatments that work for all patients. WDUN Radio, June 3, 2021
Local Volunteers Wanted for Alzheimer’s Study
Individuals between the ages 55-80 who are not currently dealing with memory issues are sought to join the AHEAD Study by participating or volunteering at more than 70 sites across the U.S. and Canada, including Dallas-Fort Worth. News Radio 1080 KRLD, June 3, 2021
UAB Participating in Clinical Trials for Alzheimer's Treatment
Among the top ten causes of death in the United States, Alzheimer's is the only one that cannot be prevented, cured or slowed, but ongoing clinical trials across the country, and UAB, are working to change that. WVTM NBC 13 Birmingham, May 26, 2021
Participants Needed for Alzheimer's Disease Study at USF Health
Researchers at the University of South Florida Byrd Alzheimer's Center and Research Institute are enrolling people for the AHEAD Study. ABC Action News Tampa Bay, March 26, 2021
5 Advances in Alzheimer’s Research and Treatment That Could Make a Difference
Improved diagnostics, new ideas for prevention, and perhaps finally a drug for the disease. Boston Globe, October 29, 2020
A Big Alzheimer's Drug Study Is Proceeding Cautiously Despite The Pandemic
After cases began emerging worldwide, thousands of clinical trials unrelated to COVID-19 were paused or canceled amid fears that participants would be infected. But now some researchers are finding ways to carry on in spite of the coronavirus. National Public Radio, October 20, 2020.
Tampa Seniors Needed for Alzheimer’s Study
Researchers at the University of South Florida are participating in a national study to prevent Alzheimer’s before it hits. Tampa Bay Times, September 30, 2020.
Ground-Breaking Alzheimer's Study Administers First Dose
The first infusion of an investigational drug that aims to delay or help to prevent the earliest memory loss due to Alzheimer’s disease took place in September at Butler Hospital in Providence, R.I., researchers announced. September 25, 2020.
Attleboro Man Becomes First in World to Take Part in Groundbreaking Alzheimer's Research
An Attleboro man has become the first in the world to take part in groundbreaking Alzheimer's research. WJAR, September 23, 2020.
Attleboro Man Gets First Infusion in Test of Drug That Could Delay or Prevent Alzheimer’s
Kalberer sees himself as a salesman for something that could help millions: participating in Alzheimer’s research. Providence Journal, September 23, 2020.
Initiation of AHEAD Study of Preclinical Alzheimer's Disease
New study initiated in the U.S. for people who have intermediate or elevated levels of amyloid in their brains. Eisai, July 14, 2020.
Clinical Trials to Begin on Antibody That Shows Promise in Treatment of Alzheimer’s
Researchers at Butler and Rhode Island Hospitals will participate in a new clinical trial of an antibody that has shown potential to help rid the brain of beta-amyloid, a protein associated with Alzheimer’s disease. Providence Journal, July 14, 2020.